Search Results - "FÄTKENHEUER, G."

CD4+ Count–Guided Interruption of Antiretroviral Treatment by El-Sadr, W M, Lundgren, J D, Neaton, J D, Gordin, F, Abrams, D, Arduino, R C, Babiker, A, Burman, W, Clumeck, N, Cohen, C J, Cohn, D, Cooper, D, Darbyshire, J, Emery, S, Fätkenheuer, G, Gazzard, B, Grund, B, Hoy, J, Klingman, K, Losso, M, Markowitz, N, Neuhaus, J, Phillips, A, Rappoport, C

“…Long-term antiretroviral therapy for the treatment of human immunodeficiency virus infection is associated with a substantial rate of complications. Structured…”
Get full text

Pretreatment human immunodeficiency virus type 1 (HIV-1) drug resistance in transmission clusters of the Cologne-Bonn region, Germany by Stecher, M., Chaillon, A., Eis-Hübinger, A.M., Lehmann, C., Fätkenheuer, G., Wasmuth, J.-C., Knops, E., Vehreschild, J.J., Mehta, S., Hoenigl, M.

“…In Germany, previous reports have demonstrated transmitted human immunodeficiency virus type 1 (HIV-1) drug-resistance mutations (DRM) in 11% of newly…”
Get full text

Outbreak of Pseudomonas aeruginosa infections after CT-guided spinal injections by Paul, G., Meißner, A., Neuneier, J., Neuschmelting, V., Grau, S., Yagdiran, A., Scheyerer, M.J., Malin, J.J., Suárez, I., Lehmann, C., Exner, M., Wiesmüller, G.A., Higgins, P.G., Seifert, H., Fätkenheuer, G., Zweigner, J., Jung, N.

“…Meningitis and spinal infections with Gram-negative bacteria after local injections for treatment of chronic back pain are rare. This study investigated an…”
Get full text

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection by Fätkenheuer, Gerd, Nelson, Mark, Lazzarin, Adriano, Konourina, Irina, Hoepelman, Andy I.M, Lampiris, Harry, Hirschel, Bernard, Tebas, Pablo, Raffi, François, Trottier, Benoit, Bellos, Nicholaos, Saag, Michael, Cooper, David A, Westby, Mike, Tawadrous, Margaret, Sullivan, John F, Ridgway, Caroline, Dunne, Michael W, Felstead, Steve, Mayer, Howard, van der Ryst, Elna

“…In key subgroups of the HIV-infected patients in the MOTIVATE 1 and MOTIVATE 2 studies, a consistent treatment benefit of maraviroc over placebo was seen at 48…”
Get full text

Predictors of serofast state after treatment for early syphilis in HIV‐infected patients by Paul, G, Wesselmann, J, Adzic, D, Malin, JJ, Suarez, I, Priesner, V, Kümmerle, T, Wyen, C, Jung, N, Bremen, K, Schlabe, S, Wasmuth, J‐C, Boesecke, C, Fätkenheuer, G, Rockstroh, J, Schwarze‐Zander, C, Lehmann, C

“…Objectives Non‐treponemal serological tests are used to monitor treatment response during syphilis infection. Syphilis‐ and HIV‐coinfected patients may…”
Get full text

Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies by Liss, B. J., Vehreschild, J. J., Cornely, O. A., Hallek, M., Fätkenheuer, G., Wisplinghoff, H., Seifert, H., Vehreschild, M. J. G. T.

“…Background In patients with haematological or oncological malignancies, we aimed to assess the rate of intestinal colonisation and blood stream infections…”
Get full text

Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi by Neuhann, F, de Forest, A, Heger, E, Nhlema, A, Scheller, C, Kaiser, R, Steffen, H M, Tweya, H, Fätkenheuer, G, Phiri, S

“…Pre-treatment drug resistance (PDR) among antiretroviral drug-naïve people living with HIV (PLHIV) represents an important indicator for the risk of treatment…”
Get full text

European AIDS Clinical Society Second Standard of Care Meeting, Brussels 16‐17 November 2016: a summary by De Wit, S, Battegay, M, D'Arminio Monforte, A, Lundgren, JD, Oprea, C, Antinori, A, Bhagani, S, Fätkenheuer, G, Friis‐Moller, N, Furrer, H, Mussini, C

“…The European AIDS Clinical Society (EACS) organized a second meeting on Standard of Care in Europe on November 16‐17 th, 2016. The aims of the meeting were to…”
Get full text

Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial by Fätkenheuer, G., Duvivier, C., Rieger, A., Durant, J., Rey, D., Schmidt, W., Hill, A., van Delft, Y., Marks, S.

“…Background Etravirine is approved for use in treatment-experienced patients at a dose of 200 mg twice daily. Efavirenz has been associated with greater…”
Get full text

An urgent call for infectious diseases specialists by Fätkenheuer, G., Kern, W. V., Salzberger, B.

Get full text

HIV DNA reservoir and elevated PD‐1 expression of CD4 T‐cell subsets particularly persist in the terminal ileum of HIV‐positive patients despite cART by Horn, C, Augustin, M, Ercanoglu, MS, Heger, E, Knops, E, Bondet, V, Duffy, D, Chon, S‐H, Nierhoff, D, Oette, M, Schäfer, H, Vivaldi, C, Held, K, Anderson, J, Geldmacher, C, Suárez, I, Rybniker, J, Klein, F, Fätkenheuer, G, Müller‐Trutwin, M, Lehmann, C

“…Objectives Despite its importance as an HIV anatomic sanctuary, little is known about the characteristics of the HIV reservoir in the terminal ileum (TI). In…”
Get full text

Higher rates of triple‐class virological failure in perinatally HIV‐infected teenagers compared with heterosexually infected young adults in Europe by Judd, A, Lodwick, R, Noguera‐Julian, A, Gibb, DM, Butler, K, Costagliola, D, Sabin, C, Sighem, A, Ledergerber, B, Torti, C, Mocroft, A, Podzamczer, D, Dorrucci, M, De Wit, S, Obel, N, Dabis, F, Cozzi‐Lepri, A, García, F, Brockmeyer, NH, Warszawski, J, Gonzalez‐Tome, MI, Mussini, C, Touloumi, G, Zangerle, R, Ghosn, J, Castagna, A, Fätkenheuer, G, Stephan, C, Meyer, L, Campbell, MA, Chene, G, Phillips, A, Mary Krause, Murielle, Leport, Catherine, Wittkop, Linda, Reiss, Peter, Wit, Ferdinand, Prins, Maria, Bucher, Heiner, Gibb, Diana, Amo, Julia Del, Thorne, Claire, Kirk, Ole, Pérez‐Hoyos, Santiago, Hamouda, Osamah, Bartmeyer, Barbara, Chkhartishvili, Nikoloz, Antinori, Andrea, Monforte, Antonella d'Arminio, Prieto, Luis, Rojo, Pablo, Soriano‐Arandes, Antoni, Battegay, Manuel, Kouyos, Roger, Tookey, Pat, Casabona, Jordi, Miró, Jose M., Konopnick, Deborah, Goetghebuer, Tessa, Sönnerborg, Anders, Teira, Ramon, Garrido, Myriam, Haerry, David, Raben, Dorthe, Chêne, Geneviève, Barger, Diana, Schwimmer, Christine, Termote, Monique, Frederiksen, Casper M., Friis‐Møller, Nina, Kjaer, Jesper, Salbøl Brandt, Rikke, Berenguer, Juan, Bohlius, Julia, Bouteloup, Vincent, Davies, Mary‐Anne, Dunn, David, Egger, Matthias, Furrer, Hansjakob, Guiguet, Marguerite, Grabar, Sophie, Lambotte, Olivier, Leroy, Valériane, Lodi, Sara, Matheron, Sophie, Monge, Susana, Nakagawa, Fumiyo, Paredes, Roger, Puoti, Massimo, Schomaker, Michael, Smit, Colette, Sterne, Jonathan, Thiebaut, Rodolphe, Thorne, Claire, Valk, Marc, Wyss, Natasha

“…Objectives The aim of the study was to determine the time to, and risk factors for, triple‐class virological failure (TCVF) across age groups for children and…”
Get full text

Clinical Outcome of HIV-Infected Patients with Discordant Virological and Immunological Response to Antiretroviral Therapy by Zoufaly, A., Heiden, M. an der, Kollan, C., Bogner, J. R., Fätkenheuer, G., Wasmuth, J. C., Stoll, M., Hamouda, O., van Lunzen, J.

“…Background. A subgroup of human immunodeficiency virus type 1 (HIV-1)—infected patients with severe immunodeficiency show persistently low CD4+ cell counts…”
Get full text

Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations by Schommers, P, Martrus, G, Matschl, U, Sirignano, M, Lütgehetmann, M, Richert, L, Hope, T J, Fätkenheuer, G, Altfeld, M

“…HIV-1-infected individuals with protective HLA class I alleles exhibit better control of viremia and slower disease progression. Virus control in these…”
Get full text

To prescribe, or not to prescribe: decision making in HIV‐1 post‐exposure prophylaxis by Scholten, M, Suárez, I, Platten, M, Kümmerle, T, Jung, N, Wyen, C, Ernst, A, Horn, C, Burst, V, Suárez, V, Rybniker, J, Fätkenheuer, G, Lehmann, C

“…Objectives We investigated the trend in usage of post‐exposure prophylaxis (PEP) after HIV‐1 risk exposure and evaluated PEP prescription decision making of…”
Get full text

Effect of an Antiretroviral Regimen Containing Ritonavir Boosted Lopinavir on Intestinal and Hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected Patients by Wyen, C, Fuhr, U, Frank, D, Aarnoutse, RE, Klaassen, T, Lazar, A, Seeringer, A, Doroshyenko, O, Kirchheiner, JC, Abdulrazik, F, Schmeisser, N, Lehmann, C, Hein, W, Schömig, E, Burger, DM, Fätkenheuer, G, Jetter, A

“…This study aimed to quantify the inhibition of cytochrome P450 (CYP3A), CYP2D6, and P‐glycoprotein in human immunodeficiency virus (HIV)‐infected patients…”
Get full text

Detection of Microsporidia in Travelers with Diarrhea by MÜLLER, A, BIALEK, R, KÄMPER, A, FÄTKENHEUER, G, SALZBERGER, B, FRANZEN, C

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study by Kaasch, A. J., Rieg, S., Kuetscher, J., Brodt, H.-R., Widmann, T., Herrmann, M., Meyer, C., Welte, T., Kern, P., Haars, U., Reuter, S., Hübner, I., Strauss, R., Sinha, B., Brunkhorst, F. M., Hellmich, M., Fätkenheuer, G., Kern, W. V., Seifert, H.

“…Objectives Early broad-spectrum antimicrobial treatment reduces mortality in patients with septic shock. In a multicenter, prospective observational study, we…”
Get full text

S184 New targets for innovative HIV treatment by Fätkenheuer, G

Get full text

Pelvic cellulitis caused by Raoultella planticola in a neutropenic patient by Al-Sawaf, O., Garcia-Borrega, J., Vehreschild, J.J., Thelen, P., Fätkenheuer, G., Shimabukuro-Vornhagen, A., Kochanek, M., Böll, B.

“…Raoultella planticola is a gram-negative, encapsulated, aerobic bacterium within the Enterobacteriaceae family. It has been primarily described as pathogen in…”
Get full text